Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …

Human papillomavirus (HPV) is the most common sexually transmitted infection among US
military members. The most frequent clinical manifestation of HPV is genital warts (GW). This …

The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to
Australian women aged 12–26 years under the National HPV Vaccination Program …

Background: Eradicating genital warts through HPV immunization could decrease STD clinic
utilization but may result in missed opportunities to diagnose other STDs. Objectives: To …

The treatment of genital warts remains frustrating since it is often painful, expensive, and
unsuccessful. Moreover, little is known about the infectivity and natural history of exophytic …

We examined the effectiveness of human papillomavirus vaccination by dose number and
spacing against incident genital warts in a cohort of 64,517 female health-plan enrollees in …

Background. Although human immunodeficiency virus (HIV)–negative men having sex with
men (MSM) bear a substantial burden of human papillomavirus (HPV)–associated disease …

Background The incidence of anogenital warts (AGW) decreased after the introduction of the
quadrivalent human papillomavirus (qHPV) vaccine in multiple jurisdictions. We studied how …

Background Human papillomavirus (HPV) vaccines were designed to prevent cervical
cancer in women and their provision remains a major public health need. However, HPV is …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …